thumbnail image
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
中文
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
HomeAbout UsDeal TeamPortfolioNewsContact Us
中文
  • Home
  • About Us
  • Deal Team
  • Portfolio
  • News
  • Contact Us
    •  

       

       

      LI XU, M.D.

      Venture Partner

    • Li Xu, M.D., is a Venture Partner with Lilly Asia Ventures (LAV). Prior to joining LAV, Li was Vice President and Head of Oncology at Hengrui, and prior to that, Vice President of Global Strategy at Pfizer. Li’s previous experience also includes Merck and Immunomedics. Li is a trained surgical oncologist who completed fellowship training at the Memorial Sloan Kettering cancer center, and also holds an M.D. from Shandong Medical University and M.B.A. from Fairleigh Dickenson.

    Company

     

    Shanghai

    Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.

     

     

    Hong Kong

    Unit 902-904, Two ChinaChem Central, 26 Des Voeux Road Central, Hong Kong

     

     

    US

    2730 Sand Hill Road, Suite 130, Menlo Park, CA

    copyright © 2018 Lilly Asia Ventures all rights reserved.

    沪ICP备12003647号

    沪公网安备 31010102005458号

      All Posts
      ×
      LillyAsiaVentures
      Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
      http://user-assets.sxlcdn.com/images/315509/FnksTvTDur7jpExbqYminmtjWgoM.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png
      Cookie Use
      We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
      Learn More